Acibadem Healthcare Group
İnternal Medicine Specialist

Ferhat Oto

Book an Appointment Free Second Opinion Verified Acibadem Specialist
Ferhat Oto
Part of the Acibadem Healthcare Network45 HospitalsInternational Patient ServicesJCI Accredited Healthcare System
Clinical Authority

Clinical Focus Areas

About Ferhat Oto, M.D.

M.D. Ferhat Oto is an internal medicine specialist trained at Dicle University Faculty of Medicine, graduating in 2013. He brings clinical experience within the Acibadem Health Group since 2022, providing comprehensive adult medical care with an emphasis on evidence-based internal medicine. He is actively involved in professional organizations, including the Turkish Medical Association and the Turkish Society of Internal Medicine and Specialization. He is also a member of the Complementary Therapies Research Association, where he engages with topics such as homeopathy and ozone therapy. M.D. Oto is committed to continuous learning and combining conventional medical practice with informed perspectives on complementary therapies to improve patient outcomes and holistic care.

Education

  • 2013 Dicle University Faculty of Medicine Internal Medicine
  • 2005 Istanbul University Cerrahpasa Faculty of Medicine

Experience

  • 2022 Acibadem Health Group
  • 2017 – 2022 Bursa Cekirge State Hospital / Internal Medicine Clinic
  • 2014 – 2017 Gaziantep Dr. Ersin Arslan Training and Research Hospital / Internal Medicine Clinic
  • 2013 – 2014 Mardin State Hospital / Internal Medicine Clinic
  • 2008 – 2013 Dicle University Faculty of Medicine / Internal Medicine Residency
  • 2007 – 2008 Dicle University Faculty of Medicine / Physiology Residency
  • 2006 – 2007 Canan Akkuş Health Center, Siirt

Memberships

  • Complementary Therapies Research Association (Homeopathy and Ozone therapy)
  • Turkish Medical Association
  • Turkish Society of Internal Medicine and Specialization

Publications

  • Evaluation of volume overload by bioelectrical impedance analysis, NT-proBNP and inferior vena cava diameter in patients with stage 3&4 and 5 chronic kidney disease
    Renal Failure, 36:4, 495-501. DOI:10.3109/0886022X.2013.875815 Yilmaz Z, Yildirim Y,Oto F, Aydin FY,Aydin E, Kadiroglu AK, Yilmaz ME.
  • Prevalence of factor XIII Val34Leu polymorphism in thrombosis cases in the southeast of Turkey and its correlation with thrombosis
    Acta Medica Mediterranea. 2017;33(1):83-87. Yildirim MS, Dal MS, KARAKUŞ A, Oto F, GÖRÜK M, RECAI M.
  • Evaluation of Characteristics and Clinical Outcomes of Patients with Acute Drug Poisoning in a University Hospital in Southeastern Anatolia Region
    Duzce Medical Journal. 2013;15(2):38-40. Yilmaz Z, Yildirim Y, Oto F, et al.
International Patient ServicesCoordinated support for patients traveling for care.
Multidisciplinary CareDoctors, hospitals and technologies aligned around the patient pathway.
Premium Healthcare ExperienceA structured, clear and reassuring medical journey.
×
Logo

29 hospitals and 15 medical centers in 5 countries.

About Us
Hospitals
Treatments
Doctors
Medical Technologies
Check Up Packages
Appointment
Blog
Contact
Contact Us
Promotional
About Us

At ACIBADEM Healthcare Group, we are committed to healthcare excellence and providing world-class healthcare services to our patients. As a leader in international healthcare, we strive to deliver the highest quality of care and meet the needs of our diverse patient population.

Read More...